SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-11-045671
Filing Date
2011-08-11
Accepted
2011-08-11 16:18:04
Documents
11
Period of Report
2011-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT v230645_10q.htm 10-Q 449151
2 EXHIBIT 31.1 v230645_ex31-1.htm EX-31.1 18949
3 EXHIBIT 31.2 v230645_ex31-2.htm EX-31.2 18851
4 EXHIBIT 32.1 v230645_ex32-1.htm EX-32.1 6994
5 EXHIBIT 32.2 v230645_ex32-2.htm EX-32.2 8056
  Complete submission text file 0001144204-11-045671.txt   1554187

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT pip-20110630.xml EX-101.INS 141097
7 XBRL TAXONOMY EXTENSION SCHEMA pip-20110630.xsd EX-101.SCH 10500
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE pip-20110630_cal.xml EX-101.CAL 28834
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pip-20110630_def.xml EX-101.DEF 62120
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE pip-20110630_lab.xml EX-101.LAB 68516
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pip-20110630_pre.xml EX-101.PRE 67008
Mailing Address ONE PARK PLACE, SUITE 450 ANNAPOLIS MD 21401
Business Address ONE PARK PLACE, SUITE 450 ANNAPOLIS MD 21401 410 269 2600
PHARMATHENE, INC (Filer) CIK: 0001326190 (see all company filings)

IRS No.: 202726770 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32587 | Film No.: 111027981
SIC: 2834 Pharmaceutical Preparations